Ciox Health, the Alpharetta, Ga.-based provider of the HealthSource clinical data analytics and management platform, announced on July 25 a $30 million equity investment led by Merck's Global Health Innovation Fund.
Ciox's service helps healthcare provider clients achieve data liquidity and improve health outcomes by streamlining access to patient records from other providers' systems and facilitating the coding and analysis of that data. The new funding will aid in the development of the Digital Patient Clone platform, which standardizes de-identified clinical data from disparate sources for research and development.
Merck's innovation fund invests in emerging digital health technology companies. Its most recent contribution will enable Ciox to partner with other companies in the fund's oncology-focused portfolio, according to managing director David Rubin, PhD, and therefore advance clinical research and the discovery of new treatments.